Offir Ukashi

16PUBLICATIONS

44CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 15, 2026

Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

|Sep 07, 2025

Vedolizumab Achieves Pan-Enteric Mucosal Healing in Crohn's Disease: A Prospective Observational Study.

Offir Ukashi, Adi Lahat, Bella Ungar

|Jun 10, 2025

The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

Uria Shani, Monica State, Radu Bogdan Mateescu

|Jan 18, 2025

Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Offir Ukashi, Aurelien Amiot, David Laharie

|Jan 08, 2025

Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn's Disease: A Mendelian Randomization Study.

Mahmud Omar, Mohammad Omar, Yonatan Shneor Patt

|Dec 19, 2024

Intestinal Ultrasound Measures are Strongly Correlated With Small Bowel Endoscopic Lewis Score in Active Crohn's Disease.

Offir Ukashi, Adi Lahat, Bella Ungar

Pageof 3

Frequent Collaborators

12 joint publications

Uri Kopylov

Adi Lahat

Shelly Soffer

Kassem Sharif

Ahmad Albshesh

Manuel Barreiro-de Acosta

Shomron Ben-Horin

Dan Carter

Rami Eliakim

Rami Eliakim

Frequent Collaborators

12 joint publications

Uri Kopylov

6 joint publications

Adi Lahat

3 joint publications

Shelly Soffer

3 joint publications

Kassem Sharif